A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Who We ARE:
Advocacy - Your Voice in State & National Advocacy
Relationships - Your Partner in Cancer Care
Education: Administration, Business, Clinical

JOIN OR RENEW NOW